| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Revive Therapeutics Ltd (OTCQB: RVVTF)
RVVTF Technical Analysis
5
| As on 12th Nov 2024 RVVTF STOCK Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.03 & Strong Sell for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RVVTFSTOCK Price
| Open | 0.01 | Change | Price | % |
| High | 0.01 | 1 Day | 0.00 | 0.00 |
| Low | 0.01 | 1 Week | 0.00 | 0.00 |
| Close | 0.01 | 1 Month | 0.00 | 0.00 |
| Volume | 191220 | 1 Year | -0.03 | -75.00 |
| 52 Week High 0.06 | 52 Week Low 0.01 | ||||
OTCQB USA Most Active Stocks
| FNMAS | 10.12 | 2.33% |
| FMCKJ | 9.73 | 0.83% |
| BMIX | 0.01 | % |
| CBDS | 0.06 | 20.00% |
| FNMA | 2.74 | 9.60% |
| BTCWF | 0.10 | 150.00% |
| ALPP | 3.56 | 0.00% |
| ALPP | 3.56 | 0.00% |
| NWBO | 0.31 | -3.12% |
| VKIN | 0.23 | 0.00% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| RVVTF Daily Charts |
RVVTF Intraday Charts |
Whats New @ Bazaartrend |
RVVTF Free Analysis |
|
|
RVVTF Important Levels Intraday
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
RVVTF Forecast December 2024
| 4th UP Forecast | 0.09 |
| 3rd UP Forecast | 0.06 |
| 2nd UP Forecast | 0.05 |
| 1st UP Forecast | 0.03 |
| 1st DOWN Forecast | -0.01 |
| 2nd DOWN Forecast | -0.03 |
| 3rd DOWN Forecast | -0.04 |
| 4th DOWN Forecast | -0.07 |
RVVTF Weekly Forecast
| 4th UP Forecast | 0.07 |
| 3rd UP Forecast | 0.05 |
| 2nd UP Forecast | 0.04 |
| 1st UP Forecast | 0.03 |
| 1st DOWN Forecast | -0.01 |
| 2nd DOWN Forecast | -0.02 |
| 3rd DOWN Forecast | -0.03 |
| 4th DOWN Forecast | -0.05 |
RVVTF Forecast2024
| 4th UP Forecast | 0.11 |
| 3rd UP Forecast | 0.08 |
| 2nd UP Forecast | 0.06 |
| 1st UP Forecast | 0.04 |
| 1st DOWN Forecast | -0.02 |
| 2nd DOWN Forecast | -0.04 |
| 3rd DOWN Forecast | -0.06 |
| 4th DOWN Forecast | -0.09 |
Revive Therapeutics Ltd ( OTCQB USA Symbol : RVVTF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RVVTF Business Profile
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. Revive Therapeutics Ltd. has a research collaboration agreement with PharmaTher Inc. for the development of psilocybin in the treatment of cancer and the discovery of other uses of undisclosed psychedelic compounds; North Carolina State University for the development of a biosynthetic version of psilocybin based on a natural biosynthesis enzymatic platform; research agreement with the University of California, San Francisco to explore the use of Bucillamine as a treatment for severe COVID-19; and collaboration with University of Health Sciences Antigua for the clinical research of psychedelics. The company was incorporated in 2012 and is headquartered in Toronto, Canada. Address: The Canadian Venture Building, Toronto, ON, Canada, M5C 1P1
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service